Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11476
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMcLeish, Andrew Ren
dc.contributor.authorLee, Sze Tingen
dc.contributor.authorByrne, Amanda Jen
dc.contributor.authorScott, Andrew Men
dc.date.accessioned2015-05-16T01:05:17Z
dc.date.available2015-05-16T01:05:17Z
dc.date.issued2011-01-07en
dc.identifier.citationANZ Journal of Surgery 2011; 82(1-2): 30-5en
dc.identifier.govdoc22507492en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/11476en
dc.description.abstractThe ability of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) to impact on management of patients with recurrent colorectal cancer is high. However, direct impact of FDG-PET on surgical management of patients with potentially resectable hepatic metastases is limited.FDG-PET scans of patients with colorectal cancer at Austin Hospital in a 2-year period were retrospectively evaluated. Data were collected on patient demographics, scan indication and sites of disease pre- and post-PET. Results of standard imaging tests and FDG-PET scans were analysed. The potential impact of FDG-PET on proposed surgical management plans was assessed by an experienced surgeon.There were 585 FDG-PET scans performed on 470 patients (309M : 161F, mean age 61.9 years) with colorectal cancer. Hepatic metastases were identified on standard imaging in 232 (39.7%) patients, and FDG-PET confirmed hepatic metastasis in 203 cases, including 22 cases with new lesions, and clarified presence of disease in 34/37 (92%) cases with equivocal standard imaging. In 54 patients, FDG-PET was performed for disease assessment before hepatic resection. FDG-PET had substantial management plan impact in 36/54 (66.7%) patients.FDG-PET can profoundly impact on the management plan of patients with colorectal cancer who may be suitable for hepatic metastectomy.en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherAged, 80 and overen
dc.subject.otherColorectal Neoplasms.pathologyen
dc.subject.otherDecision Support Techniquesen
dc.subject.otherFemaleen
dc.subject.otherFluorodeoxyglucose F18.diagnostic useen
dc.subject.otherHepatectomyen
dc.subject.otherHumansen
dc.subject.otherLiver Neoplasms.radionuclide imaging.secondary.surgeryen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherPatient Care Planningen
dc.subject.otherPositron-Emission Tomographyen
dc.subject.otherRadiopharmaceuticals.diagnostic useen
dc.subject.otherRetrospective Studiesen
dc.titleImpact of ¹⁸F-FDG-PET in decision making for liver metastectomy of colorectal cancer.en
dc.typeJournal Articleen
dc.identifier.journaltitleANZ Journal of Surgeryen
dc.identifier.affiliationDepartment of Surgery, University of Melbourne, Austin Hospital, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1111/j.1445-2197.2010.05601.xen
dc.description.pages30-5en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/22507492en
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.